(Q37776509)

23 August 2017

1 reference

title

Emerging drugs for actinic keratosis (English)

1 reference

23 August 2017

3

Eggert Stockfleth

1 reference

23 August 2017

Martina Ulrich

1

1 reference

23 August 2017

Ulrike Drecoll

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

29 July 2010

1 reference

full work available at URL

23 August 2017

http://www.informapharmascience.com/doi/abs/10.1517/14728214.2010.507191

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670178

http://www.tandfonline.com/doi/pdf/10.1517/14728214.2010.507191

13 June 2024

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

Expert Opinion on Emerging Drugs

13 June 2024

published in

1 reference

23 August 2017

volume

15

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

545-555

1 reference

Prevalence of solar damage and actinic keratosis in a Merseyside population

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Epidemiology of actinic keratoses and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

High incidence and regression rates of solar keratoses in a queensland community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

[Skin diseases in organ transplant patients]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

The actinic (solar) keratosis: a 21st-century perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Incidence and determinants of skin cancer in a high-risk Australian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Treatment of common warts and actinic keratoses by Er:YAG laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Topical diclofenac in hyaluronan gel for the treatment of solar keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

A phase II dose-ranging study of topical resiquimod to treat actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

New insights into the mode of action of anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2010.507191

Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

Solar keratosis is squamous cell carcinoma

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.

13 June 2024

14

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

[Cyclooxygenases in the skin]

13 June 2024

50

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis

13 June 2024

56

1 reference

https://api.crossref.org/works/10.1517/14728214.2010.507191

13 June 2024

Identifiers

1 reference

23 August 2017

1 reference